ConductScience.org, home

Trial · NCT01705977

Participant flow14

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Treatment Period (Year 1)STARTEDPlacebo2,009
Treatment Period (Year 1)STARTEDBelimumab 10 mg/kg2,010
Treatment Period (Year 1)Intent-to-Treat PopulationPlacebo2,002
Treatment Period (Year 1)Intent-to-Treat PopulationBelimumab 10 mg/kg2,001
Treatment Period (Year 1)COMPLETEDPlacebo1,729
Treatment Period (Year 1)COMPLETEDBelimumab 10 mg/kg1,741
Treatment Period (Year 1)NOT COMPLETEDPlacebo280
Treatment Period (Year 1)NOT COMPLETEDBelimumab 10 mg/kg269
Follow-up Period (Years 2 to 5)STARTEDPlacebo1,670
Follow-up Period (Years 2 to 5)STARTEDBelimumab 10 mg/kg1,695
Follow-up Period (Years 2 to 5)COMPLETEDPlacebo1,474
Follow-up Period (Years 2 to 5)COMPLETEDBelimumab 10 mg/kg1,514
Follow-up Period (Years 2 to 5)NOT COMPLETEDPlacebo196
Follow-up Period (Years 2 to 5)NOT COMPLETEDBelimumab 10 mg/kg181

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01705977/flow